Literature DB >> 11957787

[Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital].

Margrit Rösch1, Reiner Leidl, Stefanie Thomas, Christian von Tirpitz, Max Reinshagen, Guido Adler, Hans-Helmut König.   

Abstract

OBJECTIVE: To create a concept for measuring and valuating resource utilization of outpatient treatment of patients with inflammatory bowel disease in a German university hospital.
MATERIAL AND METHODS: The measurement of health services was achieved using a computer-based routinely administered data base of the Medical Department. Measuring costs was performed in three steps: 1. identification of the categories of resource utilization, 2. quantitative measurement of resource use, 3. monetary valuation of the utilization of resources using German fee schedules and prices for drugs.
RESULTS: The resource utilization of 272 patients with a treatment period of more than 1 year could be identified in a structured form. Categories of resource use could be identified and quantitatively measured as follows: anamnesis and physical examination by a physician in 100% of the visits, laboratory tests in 87.1%, endoscopic or sonographic services in 36.9%, and radiologic procedures in 14.1%. In 93.6% of the visits a medication was prescribed. Annual costs of outpatient care provided by the hospital were 3,171 [symbol: see text] per patient. Medication accounted for 85% of total costs. Analyzing the costs of medical treatment, mesalazine was the major cost component (48%), followed by budesonide (15%).
CONCLUSION: The presented concept offers a good access to measure costs of outpatient treatment of patients with inflammatory bowel disease. It is suitable for measuring costs in the economic evaluation of alternative treatments or diagnostic strategies in an outpatient setting. It furthermore may be used as a component in cost-of-illness studies. For transferring the concept to other hospitals, the availability of a routine documentation of services should be checked. For economic analysis, a further data management is required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11957787     DOI: 10.1007/s00063-002-1136-x

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  3 in total

1.  The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.

Authors:  Renata de S B Fróes; Ana Teresa Pugas Carvalho; Antonio Jose de V Carneiro; Adriana Maria Hilu de Barros Moreira; Jessica P L Moreira; Ronir R Luiz; Heitor S de Souza
Journal:  Eur J Health Econ       Date:  2017-05-18

2.  Health care costs and their predictors of inflammatory bowel diseases in Germany.

Authors:  Anne Prenzler; Bernd Bokemeyer; J-Matthias von der Schulenburg; Thomas Mittendorf
Journal:  Eur J Health Econ       Date:  2010-10-22

3.  [Chronic inflammatory bowel diseases competence network ].

Authors:  U R Fölsch; J Grebe; S Schreiber
Journal:  Internist (Berl)       Date:  2004-04       Impact factor: 0.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.